December 19, 2022

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

Registration is now open for the NRG Oncology Winter 2023 Meeting to be held both in Orlando and virtually, January 26-28, 2023.

Click here to register today!

(Registrations after January 3^rd will incur a late registration fee)

WINTER 2023 SYMPOSIUM

“Advances in Endometrial Cancer - Molecularly Driven Care” Thursday, Jan 26, 2023 - 8am – 12pm ET (See flyer here)

Social Media Ambassadors wanted for #NRG2023

Looking for a few good folks – in-person or virtual! Apply now to be a #NRG2023 Social Media Ambassador for the NRG Oncology Winter Meeting being held in January 26-28, 2023 in Orlando, FL! If interested, please send an e-mail (& please include your Twitter handle) to: shepardm@nrgoncology.org or send us a DM on Twitter by January 16.

AMENDMENTS

BRAIN

NRG-BN005: Amendment 3, version date: November 21, 2022 (posted on CTSU)

HEAD & NECK

NRG-HN009: Amendment 1, version date: October 25, 2022 (posted on CTSU)

FORM UPDATES

BRAIN

NRG-BN005: Per protocol amendment, the following CRF update was made:

KPS and Neurologic Function Form: the following instructions were added to form header - “If the patient has suspected neurologic deterioration in their KPS per section 4, please report the KPS evaluation done at least 7 days after the suspected deterioration first occurred.”

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Actively Recruiting MALE Patients only. Read More

2. BRAIN

NRG-BN011: The central lab (NYU Langone) will be closed on Friday, December 23, 2022; Monday, December 26, 2022; Friday, December 30, 2022; and Monday, January 2, 2023, in observance of the holiday. Please plan tissue submissions accordingly. 

3. BREAST

NRG-BR007: Study Overview Webinars are being held on January 17, 2023, at 11am ET and 4pm ET. Please see the memorandum posted on CTSU for more information and for how to register by January 12.

4. GYNECOLOGIC

Printing Biospecimen Transmittal PDFs on GYN Trials

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More

GOG-0210: Biospecimens, biomarker data, clinical data, and epidemiologic data are available for request. Please visit the NRG Oncology website for more information on this important study with the overall goal of improving the outcome and/or quality of life for patients with endometrial cancer.

NRG-GY012 and NRG-GY023: BLOOD PRESSURE CUFF SUPPLY IS VERY LIMITED - Please check your supplies on site for any overlooked cuffs prior to ordering. We request that you order only what is absolutely necessary for your site. VWR has asked that orders are limited to two blood pressure cuffs at a time. Please note that it can take up to three business days to receive cuffs after ordering, so plan accordingly. Thank you for your cooperation.  

5. HEAD & NECK

NRG-HN008 Reminder: please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important. 

6. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, NRG-CC005, and NRG/SWOG S1914. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday, January 1, 2023.

DRUG SAFETY UPDATES

Drug Safety updates have been issued for the following studies:

Request for PILOT Project Applications

Date Issued: December 1, 2022

Submission Due Date: February 17, 2023

NRG Oncology NCORP solicits PILOT projects addressing NRG NCORP Health Disparities Research (HDR) priorities. PILOT projects should generate preliminary data and address feasibility issues to inform the development of a future NCORP concept. The current focus of HDC is to move past simply documenting outcome differences to the development and testing of interventions to remedy them. Applications for this award should address committee priorities including:

• Focus 1. Development of interventional studies to decrease health disparities among disparity populations, including racial and ethnic minorities, residents in rural geographic areas, and individuals from other medically underserved groups.
• Focus 2. Testing interventional studies for optimal care of at-risk elderly.
• Focus 3. Identify optimal access to cancer screening, treatment, symptom management and surveillance among diverse disparity populations.

Please see full details located on the NRG Health Disparities Committee webpage.

Winter Holiday Closure Information

Winter holiday closure information for the NRG Oncology Operations Offices, Statistics and Data Management Centers (SDMCs), Biospecimen Banks, Serum Bank, and McKesson's Clinical Research Services is posted on the CTSU website (please see the memoranda dated December 12, 2022 for this information).

NRG Oncology Biospecimen Bank – Columbus Holiday Event

The NRG Biospecimen Bank - Columbus will be closed from 12-2 pm EST on Monday, December 12 for staff to attend a holiday event. If you need to contact the Biospecimen Bank during this time, please leave a message and someone from the bank will respond as soon as possible. Phone: 614-722-2865 or e-mail: BPCBank@nationwidechildrens.org

PUBLICATIONS REMINDERS

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

JOURNAL ARTICLES

McKenzie E, Zhang S, Zakariaee R, Guthier CV, Hakimian B, Mirhadi A, Kamrava M, Padda SK, Lewis JH, Nikolova A, Mak RH, Atkins KM. Left Anterior Descending Coronary Artery Radiation Dose Association with All-Cause Mortality in NRG Oncology Trial RTOG 0617. Int J Radiat Oncol Biol Phys. 2022 Nov 24:S0360-3016(22)03565-9. doi: 10.1016/j.ijrobp.2022.11.033. Epub ahead of print. PMID: 36436615. Read more

ACCEPTED ABSTRACTS

American Society of Clinical Oncology (ASCO) GI

Dawson LA, Winter KA, Knox JJ, Zhu A, Krishnan S, Guha C, Kachnic LA, Gillin MT, Hong TS, Craig TD, Hosni A, Chen E, Noonan A, Koay EJ, Sinha R, Lock MI, Ohri N, Dorth JA, Moughan J, Crane CH. NRG/RTOG 1112: randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC) (NCT01730937). ASCO GI. 1/19/2023. 489

Please note the following upcoming meeting and abstract submission deadline dates

UPCOMING MEETINGS

American Society of Clinical Oncology (ASCO) GI; Jan 19-21, 2023; San Francisco, CA

American Society of Clinical Oncology (ASCO) GU; Feb 16-18, 2023; San Francisco, CA

ESMO Gynaecological Cancers Annual Congress 2023; Feb 23-24, 2023; Barcelona, Spain

Society of Surgical Oncology (SSO); Feb 18-20, 2023; San Diego, CA Advanced Cancer Therapies (ACT)

Society of Surgical Oncology (SSO); March 22-25, 2023; Boston, MA

UPCOMING ABSTRACT SUBMISSION DEADLINES

American Association for Cancer Research (AACR); Apr 14-19, 2023; Orlando, FL; LBA Jan 12, 2023

American College of Radiology (ACR); May 6-10, 2023; Washington DC; due to publications committee Jan 3, 2023; meeting submission deadline Jan 13, 2023

American Society of Clinical Oncology (ASCO); Jun 2-6, 2023; Chicago, IL; due to publications committee Jan 24, 2023; meeting submission deadline Feb 14, 2023 1159 pm EST; LBA Mar 16, 2023 Noon (EST)

American Society for Radiation Oncology (ASTRO); Oct 1-4, 2023; Chicago, IL; due to publications committee Feb 9, 2023; meeting submission deadline Feb 13, 2023 1159 PT

European Society for Radiotherapy and Oncology (ESTRO); May 12-16, 2023; Vienna, Austria; LBA Jan 18, 2023, 9 pm EST

ESMO Breast Cancer Annual Congress; May 11-13, 2023; Berlin, Germany; due to publications committee Feb 7, 2023; meeting submission deadline Feb 21, 2023 TiP, LBA placeholder 9 pm CET; LBA Apr 12, 2023 9pm CntEurSummrTime